NasdaqGM - Nasdaq Real Time Price USD

Anteris Technologies Global Corp. (AVR)

4.4300
+0.9200
+(26.21%)
As of 1:04:31 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,711.0440
2,734.8210
3,200.7110
5,830.5340
Cost of Revenue
1,586.5770
1,858.0210
2,902.3280
3,925.3620
Gross Profit
1,124.4670
876.8000
298.3830
1,905.1720
Operating Expense
71,807.6380
47,664.9080
31,786.0280
18,226.1330
Operating Income
-70,683.1710
-46,788.1080
-31,487.6450
-16,320.9610
Net Non Operating Interest Income Expense
374.2500
360.9700
-438.3270
-965.6410
Other Income Expense
-1,385.1940
-336.2590
1,362.1720
115.5450
Pretax Income
-71,694.1150
-46,763.3970
-30,563.8000
-17,171.0570
Net Income Common Stockholders
-71,102.3270
-46,021.8410
-30,563.8000
-17,171.0570
Diluted NI Available to Com Stockholders
-71,102.3270
-46,021.8410
-30,563.8000
-17,171.0570
Basic EPS
-1.98
-1.28
-0.85
-0.48
Diluted EPS
-1.98
-1.28
-0.85
-0.48
Basic Average Shares
35,939.8160
35,939.8160
35,939.8160
35,939.8160
Diluted Average Shares
35,939.8160
35,939.8160
35,939.8160
35,939.8160
Total Operating Income as Reported
-73,193.1630
-48,139.9880
-31,114.2750
-16,860.5760
Total Expenses
73,394.2150
49,522.9290
34,688.3560
22,151.4950
Net Income from Continuing & Discontinued Operation
-71,102.3270
-46,021.8410
-30,563.8000
-17,171.0570
Normalized Income
-69,225.5640
-44,895.5570
-31,923.9170
-17,279.2830
Interest Income
--
428.0590
210.3820
68.5520
Interest Expense
53.8090
67.0890
648.7090
1,034.1930
Net Interest Income
374.2500
360.9700
-438.3270
-965.6410
EBIT
-71,640.3060
-46,696.3080
-29,915.0910
-16,136.8640
EBITDA
-70,243.8060
-45,538.5850
-29,141.0140
-15,496.7770
Reconciled Cost of Revenue
1,586.5770
1,015.2290
2,354.6040
3,369.1210
Reconciled Depreciation
1,396.5000
1,157.7230
774.0770
640.0870
Net Income from Continuing Operation Net Minority Interest
-71,102.3270
-46,021.8410
-30,563.8000
-17,171.0570
Total Unusual Items Excluding Goodwill
-1,876.7630
-1,126.2840
1,360.1170
108.2260
Total Unusual Items
-1,876.7630
-1,126.2840
1,360.1170
108.2260
Normalized EBITDA
-68,367.0430
-44,412.3010
-30,501.1310
-15,605.0030
12/31/2021 - 12/13/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BLFS BioLife Solutions, Inc.
24.23
+10.69%
 
BA3.SG Azenta Inc
22.60
+2.73%
 
KMTS Kestra Medical Technologies, Ltd. Common Stock
24.41
+1.71%
 
ATRC AtriCure, Inc.
33.29
+4.13%
 
STXS Stereotaxis, Inc.
1.9650
-1.26%
 
STSSW Sharps Technology, Inc.
0.0117
+7.34%
 
AZTA Azenta, Inc.
26.02
+3.85%
 
PLSE Pulse Biosciences, Inc.
18.14
-0.71%
 
AVTR Avantor, Inc.
15.70
+2.75%
 
EKSO Ekso Bionics Holdings, Inc.
0.4200
+4.22%